A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

NCT01721408 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

470

Enrollment

INDUSTRY

Sponsor class

Conditions

Intra-abdominal Infection

Interventions

DRUG: Tigecycline
DRUG: Imipenem/cilastatin

Sponsor

Pfizer